Results 251 to 260 of about 217,476 (395)

Development of a consensus molecular classifier for pancreatic ductal adenocarcinoma. [PDF]

open access: yesGenome Med
Villoslada-Blanco P   +7 more
europepmc   +1 more source

Table S1-3 from CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma

open access: gold, 2023
Toshihiro Morita   +21 more
openalex   +1 more source

Collagen Signaling via DDR1 Exacerbates Barriers to Macromolecular Drug Delivery in a 3D Model of Pancreatic Cancer Fibrosis

open access: yesSmall, EarlyView.
This work investigates the role of collagen I signaling in the fibrotic barrier to macromolecular drug delivery in pancreatic cancer. Mechanistic analyses revealed the involvement of the receptor tyrosine kinase DDR1 signaling through PI3K/AKT/mTOR.
Mayu Ohira   +14 more
wiley   +1 more source

High Burden of Pancreatic Surgery for Intraductal Papillary Mucinous Neoplasia With Low‐Grade Dysplasia and Benign Cysts: A Systematic Review and Meta‐Analysis

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Background Intraductal papillary mucinous neoplasms with low‐grade dysplasia (IPMNs w/LGD) and benign cysts, including serous cystadenomas (SCAs), are common pancreatic cystic lesions (PCLs) that are better managed conservatively. The burden of patients who undergo surgical resection for these cysts is unknown.
Samuel Tanner   +8 more
wiley   +1 more source

Identification of genetically predicted protein biomarkers and drug targets for prostate cancer via Mendelian randomization

open access: yesVIEW, EarlyView.
Prostate cancer, a leading cause of cancer in men globally, urgently requires improved diagnostic and treatment strategies. This study analyzed large genetic datasets and identified five key proteins (THBD, DST, IFI27L2, OSBPL10, PPP1R14A) that either increase or decrease cancer risk, while also exploring their roles in immune response and potential ...
Maoping Cai   +11 more
wiley   +1 more source

Organoid‐based novel technology for antitumor drug screening

open access: yesVIEW, EarlyView.
Organoids represent a cutting‐edge research model that closely mimics in vivo organ physiology, making them highly valuable for tumor immunotherapy drug screening. This review explores the integration of organoids with advanced technologies, such as gene editing, 3D bioprinting, and AI, highlighting novel fusion platforms and their applications.
Yu Su   +3 more
wiley   +1 more source

Differential Control of Growth and Identity by HNF4α Isoforms in Pancreatic Ductal Adenocarcinoma. [PDF]

open access: yesMol Cancer Res
Fang P   +10 more
europepmc   +1 more source

New Function Annotation of PROSER2 in Pancreatic Ductal Adenocarcinoma

open access: hybrid
Yu‐Sun Lee   +10 more
openalex   +1 more source

Home - About - Disclaimer - Privacy